News
Amgen Donates $1 Million to Help Japanese Disaster Victims
Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to...
Press Releases
Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue
Provepharm, a start-up specialized in the development of pharmaceutical applications, announces today that, following a one-year centralized review procedure, the European Medicines Agency’s Committee...
News
Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to China & India
The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and care of hepatitis B (HBV) and hepatitis C (HCV)...
Press Releases
TxCell names François Meyer as CEO
TxCell SA, a biotechnology company developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need, announced the appointment of...
Press Releases
Oxford Medical Diagnostics and V&F join forces in the field of mass spectrometry
Oxford Medical Diagnostics (OMD), the UK developer of breath based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of...
Articles
Scientist gets his mind around Alzheimer’s
It’s not known what causes the disease or how to cure it. And the stakes have never been higher. But one European neuroscientist is...
Press Releases
Nycomed’s novel COPD therapy roflumilast receives FDA approval
Nycomed’s US partner Forest Laboratories, Inc.announced that DalirespTM (roflumilast) was approved by the US Food and Drug Administration (FDA) as a treatment to reduce...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read